ClinicalTrials.gg
SuspendedNCT04544735Updated Sep 8, 2026

Improving Women's Function After Pelvic Radiation

An interventional study of Integrated Physical Therapy and Coping Skills Training in Sexual Dysfunction, Pelvic Floor Disorders and Gynecologic Cancer, sponsored by Duke University. Suspended at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Duke University · Not applicable, Interventional, and Supportive care

Why this study was suspended
Study is suspended due to lack of funds. Will resume as soon as funding is secured.
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of the study is to develop and test an intervention combining physical therapy (PT) and coping skills training to improve women's sexual function after pelvic radiation.

Read the detailed description

Pelvic radiation, which is a critical component in the treatment of many gynecologic, bladder, rectal and anal cancers, often results in devastating and long-lasting sexual side effects. Vaginal changes following pelvic radiation include adhesions, agglutination, fibrosis, dryness, atrophy, and stenosis. Pelvic radiation-related sexual problems are often undertreated, resulting in poor symptom management and reduced quality of life. Rehabilitation programs including pelvic floor muscle training (PFMT) and vaginal dilator exercises may help minimize post-radiation vaginal changes and related sexual problems, but use of these rehabilitation strategies is inconsistent and infrequent in routine clinical practice. For many women, engaging in these rehabilitation strategies can be difficult and adherence is low (e.g.,1% to 35% for dilator use). Barriers to engaging in PFMT and dilator exercises include lack of information, pain, embarrassment, fear, and reliving invasive treatments. There is a critical need for interventions to help women access and engage in rehabilitation following pelvic radiation treatment. We propose to develop and pilot test a novel physical therapist delivered intervention to improve women's sexual function after pelvic radiation that integrates pelvic health physical therapy interventions (i.e., vaginal dilators, PFMT) and cognitive-behavioral based coping skills training for managing symptoms and improving treatment adherence. Pelvic health physical therapy interventions have demonstrated effectiveness for treating pelvic pain and sexual pain disorders. Coping skills training interventions have demonstrated benefits for reducing symptoms and improving treatment engagement.This study includes two phases: intervention development and pilot testing. For intervention development (months 1-6), qualitative data obtained from patient and healthcare provider interviews will be used to develop and refine the integrated PT and coping skills training intervention. Using information obtained in qualitative interviews, we will develop the intervention. In pilot testing (months 7-12), we will pilot the developed intervention with women who were treated with pelvic radiation. : The specific aims of this study are to: 1) develop and refine an integrated PT and coping skills training intervention based on qualitative data from interviews with cancer survivors, oncology providers, and pelvic health physical therapists; 2) pilot the developed intervention to examine its feasibility and acceptability; and 3) examine the patterns of change and relationships among outcome variables including vaginal changes, pelvic floor function, sexual function and satisfaction, and use of rehabilitation exercises.

02

Conditions studied

  • Sexual Dysfunction
  • Pelvic Floor Disorders
  • Gynecologic Cancer

Keywords

  • Pelvic radiation
  • Sexual side effects
  • Pelvic health physical therapy
  • Cancer survivors
  • Intimacy dysfunction
03

In context

Sexual Dysfunction, Physiological

385 studies on the registry are indexed under Sexual Dysfunction, Physiological; 72 are open to participants now.

This study's planned enrollment of 12 is below the median of 72 across 263 interventional studies indexed under Sexual Dysfunction, Physiological.

Browse Sexual Dysfunction, Physiological studies →

Lead sponsor

Duke University is the lead sponsor of 2,063 studies on the registry; 273 are open to participants now.

Of its 204 completed or terminated interventional studies of FDA-regulated products, 167 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Cancer Survivors participating in the Intervention Development Interviews

Inclusion Criteria:

  • Diagnosis of non- gynecologic (cervical, endometrial, vaginal, vulvar), anal, rectal, or bladder cancer
  • Completed pelvic radiation treatment within the last 5 years
  • 18 years of age or older
  • Able to speak/read English
  • Able to give meaningful

Exclusion Criteria:

  • Major untreated or uncontrolled mental illness (e.g., schizophrenia)
  • Unable to provide informed consent

Medical Providers Participating in Intervention Development Interviews

Eligibility Criteria:

  • Oncology providers (e.g., radiation, medical, and surgical oncologists; nurses; advanced practice professionals) who provide care to women who receive pelvic radiation for gynecologic, anal, rectal or bladder cancers.
  • Physical therapists with specialized certification in pelvic health or women's health physical therapy who provide care to patients in the outpatient setting.

Cancer Survivor User Testers

Inclusion Criteria:

  • Diagnosis of non-metastatic gynecologic (cervical, endometrial, vaginal, vulvar), anal, rectal, or bladder cancer
  • Completed pelvic radiation treatment in the past 2 to 24 months
  • 18 years of age or older
  • Able to speak/read English
  • Able to give meaningful informed consent

Exclusion Criteria:

  • Major untreated or uncontrolled mental illness (e.g., schizophrenia)
  • Unable to provide informed consent
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Integrated Physical Therapy and Coping Skills Training

    The proposed intervention will will integrate two key components: pelvic health PT interventions (i.e., vaginal dilators, Pelvic Floor Muscle Training) and coping skills training for managing symptoms and improving treatment adherence. The intervention aims to improve women's sexual function after pelvic radiation

    Behavioral: Integrated Physical Therapy and Coping Skills Training

Interventions

  • BehavioralIntegrated Physical Therapy and Coping Skills Training

    The proposed intervention will provide pelvic health physical therapy interventions including: education about vaginal moisturizers and lubricants, low back and hip assessment and instruction in accommodations (e.g., strategies for accommodating sexual position of choice), instruction in vulvar massage, instruction and facilitation of vaginal dilator use, and pelvic floor muscle training (PFMT) and exercises. Women will be given a set of vaginal dilators. Cognitive behavioral techniques that have been successfully used by physical therapists in prior intervention studies will be integrated into the PT intervention including breathing and relaxation techniques, guided imagery, systematic desensitization, cognitive restructuring techniques and coping thoughts, and problem solving

06

What researchers measure

Primary outcomes

  1. Session Attendance

    Treatment feasibility will be assessed by measuring the session attendance rate for each participant

    Time frame: Following completion of the intervention, up to 12 months

  2. Attkisson & Zwick's Client Satisfaction Questionnaire

    18 item questionnaire to measure and assess consumer satisfaction with health and human services.

    Time frame: 3 months post intervention

Secondary outcomes

  1. Sexual Vaginal Changes Questionnaire

    27-item questionnaire to assess intimacy, sexual interest, sexual satisfaction, vaginal changes (lubrication, pain and bleeding) and sexual functioning

    Time frame: Baseline and 3 months post intervention

  2. Australian Pelvic Floor Questionnaire

    42 item questionnaire to assesses all pelvic floor symptoms including bladder, bowel and sexual function and prolapse symptoms

    Time frame: Baseline and 3 month post intervention

  3. PROMIS Sexual Function and Satisfaction Measure Full Profile (Female)

    27 item questionnaire to measure sexual function and satisfaction in female population with cancer in past 30 days

    Time frame: Baseline and 3 months post intervention

  4. Generalized Anxiety Disorder Screener (GAD-7)

    7-item questionnaire to assess symptoms of anxiety over the past two weeks

    Time frame: Baseline and 3 months post intervention

  5. Patient Health Questionnaire Depression Screener (PHQ-9)

    9-item questionnaire to asses depressive symptoms over the past two weeks

    Time frame: Baseline and 3 months post intervention

  6. Adherence to Rehabilitation Strategies Scale

    3 item questionnaire to assess adherence to rehabilitation strategies such as vaginal dilators, moisturizers, pelvic floor muscle exercises.

    Time frame: Baseline and 3 months post intervention

07

Study locations

1 site
  • Duke University Medical Center
    Durham, North Carolina 27705, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2020 (actual). Primary completion is estimated for Dec 2027, 86 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 4, 2020
First posted
Sep 10, 2020
StartActual
Oct 7, 2020
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Sep 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04544735
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Sep 10, 2020
Start date
Oct 7, 2020
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Sep 8, 2026

Study contacts

Rebecca Shelby, PhD
principal investigator · Duke University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion